Page last updated: 2024-10-31

neostigmine and Deficiency, Mental

neostigmine has been researched along with Deficiency, Mental in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research Excerpts

ExcerptRelevanceReference
" Ten items (age, body weight, sex, duration of general anesthesia, use of propofol, use of sevoflurane, use of nitrous oxide, use of neostigmine, treatment accompanied with bleeding, and transfusion volume) were selected as risk factors for PONV."3.77Risk factors for nausea and vomiting after day care general anesthesia in mentally challenged patients undergoing dental treatment. ( Ichinohe, T; Kaneko, Y; Miyata, M; Nakata, E; Yumura, J, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yumura, J1
Nakata, E1
Miyata, M1
Ichinohe, T1
Kaneko, Y1

Other Studies

1 other study available for neostigmine and Deficiency, Mental

ArticleYear
Risk factors for nausea and vomiting after day care general anesthesia in mentally challenged patients undergoing dental treatment.
    The Bulletin of Tokyo Dental College, 2011, Volume: 52, Issue:2

    Topics: Adolescent; Adult; Age Factors; Ambulatory Surgical Procedures; Anesthesia, Dental; Anesthesia, Gene

2011